A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy.
Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging. No diagnostic test, other than sequencing of the alpha-galactosidase A gene, is available and no biomarker has been pr...
Guardado en:
Autores principales: | Andreas D Kistler, Justyna Siwy, Frank Breunig, Praveen Jeevaratnam, Alexander Scherl, William Mullen, David G Warnock, Christoph Wanner, Derralynn A Hughes, Harald Mischak, Rudolf P Wüthrich, Andreas L Serra |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4596ac9f92c4499ea0df20e143c39816 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
por: Fernando C Fervenza, et al.
Publicado: (2008) -
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease.
por: Aurelie Nguyen Dinh Cat, et al.
Publicado: (2012) -
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
por: Marian Goicoechea, et al.
Publicado: (2021) -
Urinary proteomics to support diagnosis of stroke.
por: Jesse Dawson, et al.
Publicado: (2012) -
Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles.
por: Justyna Siwy, et al.
Publicado: (2012)